<DOC>
	<DOCNO>NCT00824057</DOCNO>
	<brief_summary>The aim study investigate effect take repeated dos AZD6280 blood level midazolam caffeine healthy volunteer</brief_summary>
	<brief_title>Effect Multiple Doses AZD6280 Pharmacokinetics Midazolam ( CYP3A4 ) Caffeine ( CYP1A2 )</brief_title>
	<detailed_description />
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Healthy male subject age 18 45 year ( inclusive ) Day 1 . Clinically relevant abnormality physical examination , vital sign , clinical chemistry , hematology urinalysis judge investigator and/or sponsor . Enrollment another concurrent investigational study intake investigational drug within 3 month intake investigational drug within period 5 half life drug prior screen visit</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Phase I</keyword>
</DOC>